Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 9, 2012
Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes
Mette Ladefoged, Karsten Buschard, Ann Maria Kruse Hansen
The Journal of Physiology
|
November 15, 2005
Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem
Robert H Balfour, Ann Maria Kruse Hansen, Stefan Trapp
Journal of Medical Case Reports
|
December 15, 2021
Recurrent autoimmune hypophysitis treated with rituximab: a case report
Maria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, et al.
The Journal of Biological Chemistry
|
May 19, 2016
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography
Eva Johansson, Jakob Lerche Hansen, Ann Maria Kruse Hansen, et al.
Molecular Metabolism
|
May 24, 2018
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Archita Agrawal, Sebastian Parlee, Diego Perez-Tilve, et al.
The Journal of Endocrinology
|
April 1, 2025
Deletion of GFRAL blunts weight lowering effects of FGF21 in female mice
Alberte Silke Buch-Rasmussen, Helle Andersen, Christina Stage, et al.
Molecular Metabolism
|
July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Patrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Molecular Metabolism
|
November 18, 2022
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
Bin Yang, Vasily M Gelfanov, Kimberley El, et al.
Journal of Medicinal Chemistry
|
July 3, 2024
NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Cell Metabolism
|
December 2, 2025
Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia
Claire H Feetham, Sam Groom, Linu M John, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
November 9, 2012
Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes
Mette Ladefoged, Karsten Buschard, Ann Maria Kruse Hansen
The Journal of Physiology
|
November 15, 2005
Neuronal responses to transient hypoglycaemia in the dorsal vagal complex of the rat brainstem
Robert H Balfour, Ann Maria Kruse Hansen, Stefan Trapp
Journal of Medical Case Reports
|
December 15, 2021
Recurrent autoimmune hypophysitis treated with rituximab: a case report
Maria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, et al.
The Journal of Biological Chemistry
|
May 19, 2016
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography
Eva Johansson, Jakob Lerche Hansen, Ann Maria Kruse Hansen, et al.
Molecular Metabolism
|
May 24, 2018
Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
Archita Agrawal, Sebastian Parlee, Diego Perez-Tilve, et al.
The Journal of Endocrinology
|
April 1, 2025
Deletion of GFRAL blunts weight lowering effects of FGF21 in female mice
Alberte Silke Buch-Rasmussen, Helle Andersen, Christina Stage, et al.
Molecular Metabolism
|
July 9, 2022
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Patrick J Knerr, Stephanie A Mowery, Jonathan D Douros, et al.
Molecular Metabolism
|
November 18, 2022
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
Bin Yang, Vasily M Gelfanov, Kimberley El, et al.
Journal of Medicinal Chemistry
|
July 3, 2024
NN1213 - A Potent, Long-Acting, and Selective Analog of Human Amylin
Kirsten Dahl, Kirsten Raun, Jakob Lerche Hansen, et al.
Cell Metabolism
|
December 2, 2025
Analog of prolactin-releasing peptide reduces body weight primarily through sustained fatty acid oxidation rather than hypophagia
Claire H Feetham, Sam Groom, Linu M John, et al.
Page
of 2